Evidence map›Paper›PMID 27488593›Full record

SynthesisThe British journal of surgery2016

Meta-analysis of colorectal cancer follow-up after potentially curative resection.

S Mokhles, F Macbeth, V Farewell, F Fiorentino, N R Williams, R N Younes, J J M Takkenberg, T Treasure

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in The British journal of surgery, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pulmonary Metastasectomy in Colorectal Cancer: updated analysis of 93 randomized patients - control survival is much better than previously assumed.Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland · 2020
    Trial
  6. Trial
  7. Colorectal cancer (CRC) monitoring by 6-monthly 18FDG-PET/CT: an open-label multicentre randomised trial.Annals of oncology : official journal of the European Society for Medical Oncology · 2018
    Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Potential value of detection of minimal residual disease in colorectal cancer following radical resection.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2024
    Article
  15. The utility of surveillance CT scans in a cohort of survivors of colorectal cancer.Journal of cancer survivorship : research and practice · 2023
    Article
  16. Review
  17. Review
  18. Article
  19. Role of subxiphoid uniportal video-assisted thoracoscopic surgery in pulmonary metastasectomy.Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

S MokhlesDepartment of Cardio-Thoracic Surgery, Erasmus University Medical Centre, Rotterdam, The Netherlands.
F MacbethWales Cancer Trials Unit, Cardiff University, Cardiff, UK.
V FarewellMedical Research Council Biostatistics Unit, Institute of Public Health, University of Cambridge, Cambridge, UK.
F FiorentinoDivision of Surgery and Cancer, and Imperial College Trials Unit, Imperial College London, London, UK.
N R WilliamsSurgical and Interventional Trials Unit, Division of Surgery and Interventional Science, Faculty of Medical Sciences, University College London, London, UK.ORCID http://orcid.org/0000-0001-6496-312X
R N YounesOncology Centre, Hospital Alemão Oswaldo Cruz, Sao Paulo, Brazil.
J J M TakkenbergDepartment of Cardio-Thoracic Surgery, Erasmus University Medical Centre, Rotterdam, The Netherlands.
T TreasureClinical Operational Research Unit, University College London, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAfter potentially curative resection of primary colorectal cancer, patients may be monitored by measurement of carcinoembryonic antigen and/or CT to detect asymptomatic metastatic disease earlier.

methodsA systematic review and meta-analysis was conducted to find evidence for the clinical effectiveness of monitoring in advancing the diagnosis of recurrence and its effect on survival. MEDLINE (Ovid), Embase, the Cochrane Library, Web of Science and other databases were searched for randomized comparisons of increased intensity monitoring compared with a contemporary standard policy after resection of primary colorectal cancer.

resultsThere were 16 randomized comparisons, 11 with published survival data. More intensive monitoring advanced the diagnosis of recurrence by a median of 10 (i.q.r. 5-24) months. In ten of 11 studies the authors reported no demonstrable difference in overall survival. Seven RCTs, published from 1995 to 2016, randomly assigned 3325 patients to a monitoring protocol made more intensive by introducing new methods or increasing the frequency of existing follow-up protocols versus less invasive monitoring. No detectable difference in overall survival was associated with more intensive monitoring protocols (hazard ratio 0·98, 95 per cent c.i. 0·87 to 1·11).

conclusionBased on pooled data from randomized trials published from 1995 to 2016, the anticipated survival benefit from surgical treatment resulting from earlier detection of metastases has not been achieved.

Indexed as

AftercareColorectal NeoplasmsHumansNeoplasm MetastasisNeoplasm Recurrence, LocalSurvival AnalysisTreatment Outcome

Identifiers

PMID27488593
PMCPMC5031212

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.